The field of traditional medicine, with its deep historical roots, offers a multitude of natural compounds with potential therapeutic benefits. Lately, ...
Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to ...
4h
NanoViricides, Inc. Has Filed its Quarterly Report – Subsequent Raise Has Fortified Fiscal Position
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
More than 60,000 units of antiviral medication were delivered to pharmacies in Astana yesterday, Health Minister Akmarl ...
Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM ESTCompany ParticipantsPeter Dannenbaum - Vice ...
Daily Voice on MSN
New H3N2 Flu Variant Spreads Rapidly, Raising Fears Of Severe Season
A fast-moving variant of the H3N2 influenza A virus is spreading worldwide, raising concerns among health experts that the ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
HOUSTON and CAMBRIDGE, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) cites an error on the S&P CapIQ platform and reiterates that its ...
Foods like citrus fruits and broccoli may boost the immune system and help you to fight illness. Learn which immunity-boosting foods to add to your diet.
Despite a recent capital raise, Shelton-based antiviral drug developer NanoViricides Inc. disclosed it does not have enough cash to fund operations beyond mid-February and will need additional ...
A live webcast of the presentation will be available here and on the Company’s website at https://ir.ateapharma.com. An archived webcast will be available on Atea’s website for at least 90 days ...
Merck (MRK) stock gains as new oral HIV tablet matches Gilead's (GILD) three-drug once-daily HIV pill Biktarvy in a Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback